Informação sobre produto
- O-(4-Hydroxy-3,5-diiodo-phenyl)-3,5-diiodo-a-methyl-DL-tyrosine ethyl esterDL-a-Methyl-thyroxine ethyl esterCG-635
- 17365-01-4
- <span class="text-smallcaps">DL</span>-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-α-methyl-, ethyl ester
- <span class="text-smallcaps">DL</span>-α-Methylthyroxine ethyl ester
- Cg 635
- D,L-a-Methylthyroxine Ethyl Ester
- Ethyl O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-alpha-methyltyrosinate
- Etiroxate [INN]
- O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-a-methyltyrosine Ethyl Ester
- Thyroxine, α-methyl-, ethyl ester, <span class="text-smallcaps">DL</span>-
- Ver mais sinónimos
- Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-α-methyl-, ethyl ester
- a-Methyl-DL-thyroxine Ethyl Ester
- tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-alpha-methyl-, ethyl ester
Etiroxate is a fatty acid that inhibits the activity of cholesterol acyltransferase (CAT) and 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) in the liver. It is used as an antileukemic agent, mainly in patients with acute myelogenous leukemia. Etiroxate has been shown to be effective against psychiatric disorders, such as schizophrenia and depression, in double-blind cross-over studies on animals. Etiroxate also has a beneficial effect on cardiac function and hyperlipoproteinemia in humans. Etiroxate suppresses symptoms of these conditions by inhibiting the activity of HMGCR and CAT.
Propriedades químicas
Consulta técnica sobre: 3D-FE23191 Etiroxate
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.